DH
Insider
David Happel
President & CEODavid Happel (President & CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Sagimet Biosciences Inc. (SGMT). The largest single filing was $497K of SGMT (64,051 sh × $7.76, as filed), executed Jul 20.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$497K
shares × price, as filed
Last traded
Jul 20
Filed Jul 22
Median ADV $12.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
SGMTRecent filings
SGMTSALE
Sagimet Biosciences Inc.
View filing →
$497K64,051 sh × $7.76
Exec Jul 20
Filed Jul 22 · 4:05 PM ET SGMTSALE Sagimet Biosciences Inc. View filing → $598K
65,478 sh × $9.13
Exec Jul 21 2025
Filed Jul 23 2025 · 5:30 PM ET